{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:25:30Z","timestamp":1786980330642,"version":"build-2736575974"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,18]],"date-time":"2017-11-18T00:00:00Z","timestamp":1510963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Spine J"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00586-017-5387-x","type":"journal-article","created":{"date-parts":[[2017,11,18]],"date-time":"2017-11-18T09:56:25Z","timestamp":1510998985000},"page":"21-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Safety of intrathecal route: focus to methylprednisolone acetate (Depo-Medrol) use"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4443-8843","authenticated-orcid":false,"given":"Jo\u00ebl","family":"Schlatter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le","family":"Zamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofiane","family":"Kabiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Eudes","family":"Fontan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cisternino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,18]]},"reference":[{"key":"5387_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0140-6736(81)90875-8","volume":"2","author":"DW Coombs","year":"1981","unstructured":"Coombs DW, Saunders RL, Gaylor MS, Pageau M, Leith MG, Shaiberger C (1981) Continuous epidural analgesia via implanted morphine reservoir. Lancet 2:425\u2013426","journal-title":"Lancet"},{"key":"5387_CR2","first-page":"516","volume":"56","author":"BM Onofrio","year":"1981","unstructured":"Onofrio BM, Yaksh TL, Arnold PG (1981) Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clin Proc 56:516\u2013520","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"5387_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S1040-8428(00)00115-3","volume":"37","author":"JZ Kerr","year":"2001","unstructured":"Kerr JZ, Berg S, Blaney SM (2001) Intrathecal chemotherapy. Crit Rev Oncol Hematol 37(3):227\u2013236","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"5387_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/NCC.0000000000000108","volume":"37","author":"PJ Gilbar","year":"2014","unstructured":"Gilbar PJ (2014) Intrathecal chemotherapy: potential for medication error. Cancer Nurs 37(4):299\u2013309","journal-title":"Cancer Nurs"},{"issue":"1","key":"5387_CR5","first-page":"65","volume":"15","author":"NC Varhabhatla","year":"2012","unstructured":"Varhabhatla NC, Zuo Z (2012) Rising complication rates after intrathecal catheter and pump placement in the pediatric population: analysis of national data between 1997 and 2006. Pain Phys 15(1):65\u201374","journal-title":"Pain Phys"},{"key":"5387_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3171\/jns.1995.83.2.0215","volume":"83","author":"RD Penn","year":"1995","unstructured":"Penn RD, York MM, Paice JA (1995) Catheter systems for intrathecal drug delivery. J Neurosurg 83:215\u2013217","journal-title":"J Neurosurg"},{"issue":"4","key":"5387_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.spmd.2004.02.004","volume":"1","author":"JS Przybyl","year":"2003","unstructured":"Przybyl JS, Follett KA, Caraway D (2003) Intrathecal drug therapy: general considerations. Sem Pain Med 1(4):228\u2013233","journal-title":"Sem Pain Med"},{"key":"5387_CR8","first-page":"1","volume":"24","author":"F Motta","year":"2016","unstructured":"Motta F, Antonello CE (2016) Comparison between an Ascenda and a silicone catheter in intrathecal baclofen therapy in pediatric patients: analysis of complications. J Neurosurg Pediatr 24:1\u20136","journal-title":"J Neurosurg Pediatr"},{"issue":"3","key":"5387_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00277-008-0645-y","volume":"88","author":"YL Kwong","year":"2009","unstructured":"Kwong YL, Yeung DY, Chan JC (2009) Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities. Ann Hematol 88(3):193\u2013201","journal-title":"Ann Hematol"},{"issue":"3","key":"5387_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3344\/kjp.2014.27.3.297","volume":"27","author":"JJ Monsivais","year":"2014","unstructured":"Monsivais JJ, Monsivais DB (2014) The long-term safety and efficacy of intrathecal therapy using sufentanil in chronic intractable non-malignant pain. Korean J Pain 27(3):297\u2013300","journal-title":"Korean J Pain"},{"issue":"3","key":"5387_CR11","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10549-011-1417-2","volume":"127","author":"M Oliveira","year":"2011","unstructured":"Oliveira M, Braga S, Passos-Coelho JL, Fonseca R, Oliveira J (2011) Complete response in HER2+\u00a0leptomeningeal carcinomatosis from breast cancer with intrathecal trastuzumab. Breast Cancer Res Treat 127(3):841\u2013844","journal-title":"Breast Cancer Res Treat"},{"issue":"13","key":"5387_CR12","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.2174\/1389450115666141029234644","volume":"15","author":"M Bonnan","year":"2014","unstructured":"Bonnan M, Ferrari S, Bertandeau E, Demasles S, Krim E, Miquel M et al (2014) Intrathecal rituximab therapy in multiple sclerosis: review of evidence supporting the need for future trials. Curr Drug Targets 15(13):1205\u20131214","journal-title":"Curr Drug Targets"},{"issue":"2","key":"5387_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000441380","volume":"61","author":"T Chotsampancharoen","year":"2016","unstructured":"Chotsampancharoen T, Sripornsawan P, Wongchanchailert M (2016) Two fatal cases of accidental intrathecal vincristine administration: learning from death events. Chemotherapy 61(2):108\u2013110","journal-title":"Chemotherapy"},{"issue":"5","key":"5387_CR14","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1111\/j.1556-4029.2006.00241.x","volume":"51","author":"G Tournel","year":"2006","unstructured":"Tournel G, B\u00e9cart-Robert A, Courtin P, H\u00e9douin V, Gosset D (2006) Fatal accidental intrathecal injection of vindesine. J Forensic Sci 51(5):1166\u20131168","journal-title":"J Forensic Sci"},{"key":"5387_CR15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3949\/ccjm.27.4.198","volume":"27","author":"AD Sehgal","year":"1960","unstructured":"Sehgal AD, Gardner WJ (1960) Corticosteroids administered intradurally for relief of sciatica. Cleve Clin Q 27:198\u2013201","journal-title":"Cleve Clin Q"},{"key":"5387_CR16","first-page":"275","volume":"88","author":"AD Sehgal","year":"1963","unstructured":"Sehgal AD, Gardner WJ (1963) Place of intrathecal methylprednisolone acetate in neurological disorders. Trans Am Neurol Assoc 88:275\u2013276","journal-title":"Trans Am Neurol Assoc"},{"issue":"1","key":"5387_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4103\/0970-5333.114857","volume":"27","author":"S Singh","year":"2013","unstructured":"Singh S, Gupta R, Kaur S, Kaur J (2013) Post-herpetic neuralgia: a review of current management strategies. Indian J Pain 27(1):12\u201321","journal-title":"Indian J Pain"},{"issue":"21","key":"5387_CR18","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1056\/NEJM200011233432102","volume":"343","author":"N Kotani","year":"2000","unstructured":"Kotani N, Kushikata T, Hashimoto H, Kimura F, Muraoka M, Yodono M et al (2000) Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med 343(21):1514\u20131519","journal-title":"N Engl J Med"},{"key":"5387_CR19","first-page":"287","volume":"24","author":"A Kikuchi","year":"1999","unstructured":"Kikuchi A, Kotani N, Sato T, Takamura K, Sakai I, Matsuki A (1999) Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for long-term analgesia in patients with intractable postherpetic neuralgia. Reg Anesth Pain Med 24:287\u2013293","journal-title":"Reg Anesth Pain Med"},{"key":"5387_CR20","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2401960","volume":"14","author":"E Vilmer","year":"2000","unstructured":"Vilmer E, Suciu S, Ferster A, Bertrand Y, Cav\u00e9 H, Thyss A et al (2000) Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report\u2014Children Leukemia Cooperative Group. Leukemia 14:2257\u20132266","journal-title":"Leukemia"},{"issue":"2","key":"5387_CR21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1182\/blood.V84.2.355.355","volume":"84","author":"D Pinkel","year":"1994","unstructured":"Pinkel D, Woo S (1994) Prevention and treatment of meningeal leukemia in children. Blood 84(2):355\u2013366","journal-title":"Blood"},{"issue":"4","key":"5387_CR22","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1182\/blood-2005-12-011809","volume":"108","author":"Y Matloub","year":"2006","unstructured":"Matloub Y, Lindemulder S, Gaynon PS, Sather H, La M, Broxson E et al (2006) Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children\u2019s Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children\u2019s Oncology Group. Blood 108(4):1165\u20131173","journal-title":"Blood"},{"key":"5387_CR23","unstructured":"National Institute of Cancer (2016) Les sp\u00e9cificit\u00e9s des cancers des enfants et des adolescents. Available at: http:\/\/www.e-cancer.fr\/Professionnels-de-sante\/L-organisation-de-l-offre-de-soins\/Cancerologie-pediatrique\/Les-specificites-des-cancers-des-enfants-et-des-adolescents . Accessed June 2016"},{"issue":"6","key":"5387_CR24","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/00043426-200208000-00002","volume":"24","author":"J Donadieu","year":"2002","unstructured":"Donadieu J, Hill C (2002) Clinical trials in childhood acute lymphoblastic leukemia: a common prognostic classification and a common induction therapy are now warranted. J Pediatr Hematol Oncol 24(6):424\u2013425","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"5387_CR25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1046\/j.1365-2141.1998.00818.x","volume":"102","author":"J Donadieu","year":"1998","unstructured":"Donadieu J, Auclerc MF, Baruchel A, Leblanc T, Landman-Parker J, Perel Y et al (1998) Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables. Fralle Group. French Acute Lymphoblastic Leukaemia Study Group. Br J Haematol 102(3):729\u2013739","journal-title":"Br J Haematol"},{"issue":"12","key":"5387_CR26","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1054\/bjoc.2000.1504","volume":"83","author":"J Donadieu","year":"2000","unstructured":"Donadieu J, Auclerc MF, Baruchel A, Perel Y, Bordigoni P, Landman-Parker J et al (2000) Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE). Br J Cancer 83(12):1617\u20131622","journal-title":"Br J Cancer"},{"issue":"9617","key":"5387_CR27","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","volume":"371","author":"CH Pui","year":"2008","unstructured":"Pui CH, Robison LL, Look AT (2008) Acute lymphoblastic leukaemia. Lancet 371(9617):1030\u20131043","journal-title":"Lancet"},{"issue":"2","key":"5387_CR28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1182\/blood.V92.2.411","volume":"92","author":"CH Pui","year":"1998","unstructured":"Pui CH, Mahmoud HH, Rivera GK, Hancock ML, Sandlund JT, Behm FG et al (1998) Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. Blood 92(2):411\u2013415","journal-title":"Blood"},{"issue":"17","key":"5387_CR29","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1200\/JCO.2013.54.5020","volume":"32","author":"HC Liu","year":"2014","unstructured":"Liu HC, Yeh TC, Hou JY, Chen KH, Huang TH, Chang CY et al (2014) Triple intrathecal therapy alone with omission of cranial radiation in children with acute lymphoblastic leukemia. J Clin Oncol 32(17):1825\u20131829","journal-title":"J Clin Oncol"},{"key":"5387_CR30","first-page":"214","volume":"86","author":"WJ Gardner","year":"1961","unstructured":"Gardner WJ, Goebert HW, Sehgal AD (1961) Intraspinal corticosteroids in the treatment of sciatica. Trans Am Neurol Assoc 86:214\u2013215","journal-title":"Trans Am Neurol Assoc"},{"key":"5387_CR31","first-page":"243","volume":"95","author":"NP Goldstein","year":"1970","unstructured":"Goldstein NP, McGuckin WF, McKenzie BF, Mattox VR (1970) Experimental intrathecal administration of methylprednisolone acetate in multiple sclerosis. Trans Am Neurol Assoc 95:243\u2013244","journal-title":"Trans Am Neurol Assoc"},{"issue":"2","key":"5387_CR32","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1600-0404.1973.tb01289.x","volume":"49","author":"DA Nelson","year":"1973","unstructured":"Nelson DA, Vates TS Jr, Thomas RB Jr (1973) Complications from intrathecal steroid therapy in patients with multiple sclerosis. Acta Neurol Scand 49(2):176\u2013188","journal-title":"Acta Neurol Scand"},{"issue":"11","key":"5387_CR33","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1136\/jnnp.39.11.1124","volume":"39","author":"JL Bernat","year":"1976","unstructured":"Bernat JL, Sadowsky CH, Vincent FM, Nordgren RE, Margolis G (1976) Sclerosing spinal pachymeningitis. A complication of intrathecal administration of Depo-Medrol for multiple sclerosis. J Neurol Neurosurg Psychiatry 39(11):1124\u20131128","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"5387_CR34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5694\/j.1326-5377.1984.tb104038.x","volume":"140","author":"J Roche","year":"1984","unstructured":"Roche J (1984) Steroid-induced arachnoiditis. Med J Aust 140(5):281\u2013284","journal-title":"Med J Aust"},{"issue":"1","key":"5387_CR35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5694\/j.1326-5377.1991.tb116371.x","volume":"155","author":"A Johnson","year":"1991","unstructured":"Johnson A, Ryan MD, Roche J (1991) Depo-Medrol and myelographic arachnoiditis. Med J Aust 155(1):18\u201320","journal-title":"Med J Aust"},{"issue":"5","key":"5387_CR36","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/j.1532-2149.2012.00233.x","volume":"17","author":"M Rijsdijk","year":"2013","unstructured":"Rijsdijk M, van Wijck AJ, Meulenhoff PC, Kavelaars A, van der Tweel I, Kalkman CJ (2013) No beneficial effect of intrathecal methylprednisolone acetate in postherpetic neuralgia patients. Eur J Pain 17(5):714\u2013723","journal-title":"Eur J Pain"},{"issue":"5","key":"5387_CR37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.36076\/ppj.2010\/13\/493","volume":"13","author":"RM Lima","year":"2010","unstructured":"Lima RM, Navarro LH, Carness JM, Barros GA, Marques ME, Solanki D et al (2010) Clinical and histological effects of the intrathecal administration of methylprednisolone in dogs. Pain Phys 13(5):493\u2013501","journal-title":"Pain Phys"},{"issue":"1","key":"5387_CR38","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/ALN.0b013e31823cf035","volume":"116","author":"M Rijsdijk","year":"2012","unstructured":"Rijsdijk M, van Wijck AJ, Kalkman CJ, Meulenhoff PC, Grafe MR, Steinauer J et al (2012) Safety assessment and pharmacokinetics of intrathecal methylprednisolone acetate in dogs. Anesthesiology 116(1):170\u2013181","journal-title":"Anesthesiology"},{"key":"5387_CR39","unstructured":"Food and Drug Administration (FDA) (2016) Depo-Medrol label information. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/011757s103lbl.pdf . Accessed June 2016"},{"key":"5387_CR40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/jps.3030350308","volume":"35","author":"JW Nelson","year":"1946","unstructured":"Nelson JW, Lyster SC (1946) The toxicity of myristyl-gamma-picolinium chloride. J Am Pharm Assoc Am Pharm Assoc 35:89\u201394","journal-title":"J Am Pharm Assoc Am Pharm Assoc"},{"issue":"7","key":"5387_CR41","first-page":"2360","volume":"34","author":"E Zemel","year":"1993","unstructured":"Zemel E, Loewenstein A, Lazar M, Perlman I (1993) The effects of myristyl gamma-picolinium chloride on the rabbit retina: morphologic observations. Invest Ophthalmol Vis Sci 34(7):2360\u20132366","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"5387_CR42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1034\/j.1600-0536.2001.44020923.x","volume":"44","author":"G Farm","year":"2001","unstructured":"Farm G, Erikssohn I (2001) Contact allergy to miripirium chloride in Depo-Medrol. Contact Dermat 44(2):127","journal-title":"Contact Dermat"},{"issue":"12","key":"5387_CR43","first-page":"3053","volume":"32","author":"A Loewenstein","year":"1991","unstructured":"Loewenstein A, Zemel E, Lazar M, Perlman I (1991) The effects of Depo-Medrol preservative on the rabbit visual system. Invest Ophthalmol Vis Sci 32(12):3053\u20133060","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"5387_CR44","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1001\/archderm.1985.01660020116033","volume":"121","author":"CG Mathias","year":"1985","unstructured":"Mathias CG, Robertson DB (1985) Delayed hypersensitivity to a corticosteroid suspension containing methylprednisolone. Two cases of conjunctival inflammation after retrobulbar injection. Arch Dermatol 121(2):258\u2013261","journal-title":"Arch Dermatol"},{"issue":"5","key":"5387_CR45","doi-asserted-by":"crossref","first-page":"E609","DOI":"10.36076\/ppj.2014\/17\/E609","volume":"17","author":"NN Knezevic","year":"2014","unstructured":"Knezevic NN, Candido KD, Cokic I, Krbanjevic A, Berth SL, Knezevic I (2014) Cytotoxic effect of commercially available methylprednisolone acetate with and without reduced preservatives on dorsal root ganglion sensory neurons in rats. Pain Phys 17(5):E609\u2013E618","journal-title":"Pain Phys"},{"issue":"6","key":"5387_CR46","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1213\/00000539-198706000-00012","volume":"66","author":"HT Benzon","year":"1987","unstructured":"Benzon HT, Gissen AJ, Strichartz GR, Avram MJ, Covino BG (1987) The effect of polyethylene glycol on mammalian nerve impulses. Anesth Analg 66(6):553\u2013559","journal-title":"Anesth Analg"},{"issue":"7","key":"5387_CR47","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1001\/archneur.1988.00520310122029","volume":"45","author":"DA Nelson","year":"1988","unstructured":"Nelson DA (1988) Dangers from methylprednisolone acetate therapy by intraspinal injection. Arch Neurol 45(7):804\u2013806","journal-title":"Arch Neurol"},{"issue":"6","key":"5387_CR48","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1213\/ANE.0b013e31823526d7","volume":"113","author":"KD Candido","year":"2011","unstructured":"Candido KD, Knezevic I, Mukalel J, Knezevic NN (2011) Enhancing the relative safety of intentional or unintentional intrathecal methylprednisolone administration by removing polyethylene glycol. Anesth Analg 113(6):1487\u20131489","journal-title":"Anesth Analg"},{"key":"5387_CR49","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0002-9440(10)64779-7","volume":"157","author":"JC Reed","year":"2000","unstructured":"Reed JC (2000) Mechanisms of apoptosis. Am J Pathol 157:1415\u20131430","journal-title":"Am J Pathol"},{"issue":"9","key":"5387_CR50","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.2106\/JBJS.G.01182","volume":"90","author":"GO Okubadejo","year":"2008","unstructured":"Okubadejo GO, Talcott MR, Schmidt RE, Sharma A, Patel AA, Mackey RB et al (2008) Perils of intravascular methylprednisolone injection into the vertebral artery. An animal study. J Bone Jt Surg Am 90(9):1932\u20131938","journal-title":"J Bone Jt Surg Am"},{"key":"5387_CR51","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.freeradbiomed.2005.01.004","volume":"38","author":"I Beck-Speier","year":"2005","unstructured":"Beck-Speier I, Dayal N, Karg E, Maier KL, Schumann G, Schulz H et al (2005) Oxidative stress and lipid mediators induced in alveolar macrophages by ultrafine particles. Free Radic Biol Med 38:1080\u20131092","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"5387_CR52","first-page":"405","volume":"39","author":"K Donaldson","year":"2003","unstructured":"Donaldson K, Stone V (2003) Current hypotheses on the mechanisms of toxicity of ultrafine particles. Ann Ist Super Sanita 39(3):405\u2013410","journal-title":"Ann Ist Super Sanita"},{"key":"5387_CR53","first-page":"1159","volume":"105","author":"KE Driscoll","year":"1997","unstructured":"Driscoll KE, Carter JM, Hassenbein DG, Howard B (1997) Cytokines and particle-induced inflammatory cell recruitment. Environ Health Perspect 105:1159\u20131164","journal-title":"Environ Health Perspect"},{"issue":"11","key":"5387_CR54","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1002\/jps.10154","volume":"91","author":"MJ Akers","year":"2002","unstructured":"Akers MJ (2002) Excipient\u2013drug interactions in parenteral formulations. J Pharm Sci 91(11):2283\u20132300","journal-title":"J Pharm Sci"},{"issue":"2","key":"5387_CR55","first-page":"128","volume":"3","author":"LK Golightly","year":"1988","unstructured":"Golightly LK, Smolinske SS, Bennett ML, Sutherland EW, Rumack BH (1988) Pharmaceutical excipients. Adverse effects associated with inactive ingredients in drug products (Part I). Med Toxicol Adverse Drug Exp 3(2):128\u2013165","journal-title":"Med Toxicol Adverse Drug Exp"},{"issue":"4","key":"5387_CR56","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1046\/j.1365-2273.2002.00584.x","volume":"27","author":"S Sood","year":"2002","unstructured":"Sood S, Strachan DR, Tsikoudas A, Stables GI (2002) Allergic otitis externa. Clin Otolaryngol Allied Sci 27(4):233\u2013236","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"5387_CR57","doi-asserted-by":"crossref","unstructured":"No authors listed (2009) What are excipients doing in medicinal products? Drug Ther Bull 47(7):81\u201384","DOI":"10.1136\/dtb.2009.06.0026"},{"key":"5387_CR58","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.phrs.2011.01.006","volume":"63","author":"V Fabiano","year":"2011","unstructured":"Fabiano V, Mameli C, Zuccotti GV (2011) Paediatric pharmacology: remember the excipients. Pharmacol Res 63:362\u2013365","journal-title":"Pharmacol Res"},{"issue":"3","key":"5387_CR59","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0022-3476(78)81183-4","volume":"93","author":"K Arulanantham","year":"1978","unstructured":"Arulanantham K, Genel M (1978) Central nervous system toxicity associated with ingestion of propylene glycol. J Pediatr 93(3):515\u2013516","journal-title":"J Pediatr"},{"issue":"3","key":"5387_CR60","doi-asserted-by":"publisher","first-page":"196","DOI":"10.4103\/0971-5851.190354","volume":"37","author":"S Gulia","year":"2016","unstructured":"Gulia S, Gupta S, Singh A (2016) Intrathecal trastuzumab for leptomeningeal carcinomatosis in patients with human epidermal growth factor receptor 2 positive breast cancer. Indian J Med Paediatr Oncol 37(3):196\u2013198","journal-title":"Indian J Med Paediatr Oncol"},{"key":"5387_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2342","author":"JK Doorduijn","year":"2016","unstructured":"Doorduijn JK, van Imhoff GW, van der Holt B, Schouten HC, Schaafsma MR, MacKenzie MA et al (2016) Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study. Hematol Oncol. https:\/\/doi.org\/10.1002\/hon.2342 (epub ahead of print)","journal-title":"Hematol Oncol"},{"issue":"1","key":"5387_CR62","first-page":"26714","volume":"6","author":"F Safari","year":"2016","unstructured":"Safari F, Aminnejad R, Mohajerani SA, Farivar F, Mottaghi K, Safdari H (2016) Intrathecal dexmedetomidine and fentanyl as adjuvant to bupivacaine on duration of spinal block in addicted patients. Anesth Pain Med 31 6(1):26714","journal-title":"Anesth Pain Med 31"},{"issue":"86","key":"5387_CR63","first-page":"221","volume":"28","author":"S Tandon","year":"2016","unstructured":"Tandon S, Singh S, Sharma S, Lahiri AK (2016) Use of intrathecal fluorescein in recurrent meningitis after cochlear implantation. Iran J Otorhinolaryngol 28(86):221\u2013226","journal-title":"Iran J Otorhinolaryngol"},{"issue":"9","key":"5387_CR64","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1111\/aas.12763","volume":"60","author":"P Antunes","year":"2016","unstructured":"Antunes P, Perdig\u00e3o M (2016) The use of intrathecal fluorescein in cerebrospinal fluid leak repair: management from an anesthesiologist\u2019s point-of-view. Acta Anaesthesiol Scand 60(9):1323\u20131327","journal-title":"Acta Anaesthesiol Scand"},{"issue":"3","key":"5387_CR65","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3171\/2014.12.JNS14995","volume":"124","author":"SM Raza","year":"2016","unstructured":"Raza SM, Banu MA, Donaldson A, Patel KS, Anand VK, Schwartz TH (2016) Sensitivity and specificity of intrathecal fluorescein and white light excitation for detecting intraoperative cerebrospinal fluid leak in endoscopic skull base surgery: a prospective study. J Neurosurg 124(3):621\u2013626","journal-title":"J Neurosurg"},{"issue":"2","key":"5387_CR66","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/1097-0142(197202)29:2<370::AID-CNCR2820290217>3.0.CO;2-Z","volume":"29","author":"JH Saiki","year":"1972","unstructured":"Saiki JH, Thompson S, Smith F, Atkinson R (1972) Paraplegia following intrathecal chemotherapy. Cancer 29(2):370\u2013374","journal-title":"Cancer"},{"issue":"2","key":"5387_CR67","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0041-008X(73)80001-8","volume":"25","author":"FH DeLand","year":"1973","unstructured":"DeLand FH (1973) Intrathecal toxicity studies with benzyl alcohol. Toxicol Appl Pharmacol 25(2):153\u2013156","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"5387_CR68","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1213\/00000539-197703000-00011","volume":"56","author":"DB Craig","year":"1977","unstructured":"Craig DB, Habib GG (1977) Flaccid paraparesis following obstetrical epidural anesthesia: possible role of benzyl alcohol. Anesth Analg 56(2):219\u2013221","journal-title":"Anesth Analg"},{"issue":"6","key":"5387_CR69","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/bja\/55.6.541","volume":"55","author":"D Niv","year":"1983","unstructured":"Niv D, Whitwam JG, Loh L (1983) Depression of nociceptive sympathetic reflexes by the intrathecal administration of midazolam. Br J Anaesth 55(6):541\u2013547","journal-title":"Br J Anaesth"},{"issue":"8","key":"5387_CR70","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1212\/WNL.33.8.1032","volume":"33","author":"AF Hahn","year":"1983","unstructured":"Hahn AF, Feasby TE, Gilbert JJ (1983) Paraparesis following intrathecal chemotherapy. Neurology 33(8):1032\u20131032","journal-title":"Neurology"},{"issue":"3","key":"5387_CR71","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1365-2044.1973.tb00450.x","volume":"28","author":"M Swerdlow","year":"1973","unstructured":"Swerdlow M (1973) Intrathecal chlorocresol. Anaesthesia 28(3):297\u2013301","journal-title":"Anaesthesia"},{"issue":"6","key":"5387_CR72","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1097\/00000542-198712000-00020","volume":"67","author":"SL Pen Du","year":"1987","unstructured":"Du Pen SL, Ramsey D, Chin S (1987) Chronic epidural morphine and preservative-induced injury. Anesthesiology 67(6):987\u2013988","journal-title":"Anesthesiology"},{"issue":"4","key":"5387_CR73","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3171\/SPI\/2008\/8\/4\/390","volume":"8","author":"F Rincon","year":"2008","unstructured":"Rincon F, Mocco J, Komotar RJ, Khandji AG, McCormick PC, Olarte M (2008) Chronic myelopathy due to a giant spinal arachnoid cyst: a complication of the intrathecal injection of phenol. J Neurosurg Spine 8(4):390\u2013393","journal-title":"J Neurosurg Spine"},{"issue":"1","key":"5387_CR74","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/00000542-199301000-00016","volume":"78","author":"JM Malinovsky","year":"1993","unstructured":"Malinovsky JM, Lepage JY, Cozian A, Mussini JM, Pinaudt M, Souron R (1993) Is ketamine or its preservative responsible for neurotoxicity in the rabbit? Anesthesiology 78(1):109\u2013115","journal-title":"Anesthesiology"},{"issue":"2","key":"5387_CR75","first-page":"317","volume":"85","author":"MS Gurun","year":"1997","unstructured":"Gurun MS, Leinbach R, Moore L, Lee CS, Owen MD, Eisenach JC (1997) Studies on the safety of glucose and paraben-containing neostigmine for intrathecal administration. Anesth Analg 85(2):317\u2013323","journal-title":"Anesth Analg"},{"issue":"4","key":"5387_CR76","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1213\/00000539-198404000-00013","volume":"63","author":"BC Wang","year":"1984","unstructured":"Wang BC, Hillman DE, Spielholz NI, Turndorf H (1984) Chronic neurological deficits and Nesacaine-CE\u2013an effect of the anesthetic, 2-chloroprocaine, or the antioxidant, sodium bisulfite? Anesth Analg 63(4):445\u2013447","journal-title":"Anesth Analg"},{"issue":"4","key":"5387_CR77","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/00000542-198510000-00004","volume":"63","author":"LB Ready","year":"1985","unstructured":"Ready LB, Plumer MH, Haschke RH, Austin E, Sumi SM (1985) Neurotoxicity of intrathecal local anesthetics in rabbits. Anesthesiology 63(4):364\u2013370","journal-title":"Anesthesiology"}],"container-title":["European Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00586-017-5387-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-017-5387-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00586-017-5387-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T12:50:43Z","timestamp":1659876643000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00586-017-5387-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,18]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["5387"],"URL":"https:\/\/doi.org\/10.1007\/s00586-017-5387-x","relation":{},"ISSN":["0940-6719","1432-0932"],"issn-type":[{"value":"0940-6719","type":"print"},{"value":"1432-0932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,18]]},"assertion":[{"value":"13 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}